The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer
- PMID: 35604626
- DOI: 10.1007/s11033-022-07590-z
The deadly cross-talk between Hippo pathway and epithelial-mesenchymal transition (EMT) in cancer
Abstract
Hippo signaling pathway is an evolutionarily conserved network that regulates organ size growth and tissue regeneration. Hippo signaling dysfunction results in uncontrolled cell proliferation and influences cell differentiation. Aberrant Hippo pathway signaling is implicated in cancer progression, by promoting cell proliferation, cancer stem cell properties, chemoresistance and metastatic capacity. Epithelial-mesenchymal transition (EMT) is also well known to be implicated in carcinogenesis. Loss of cell polarity, disruption of cell-cell junctions and cytoskeletal remodeling are essential during EMT. At the same time, signals related to intercellular contact, cell-extracellular matrix contact, polarity and mechanotransduction are included in the list of regulatory inputs into Hippo pathway. Therefore, the emerging association between Hippo pathway and EMT in cancer is not surprising. Recent studies have begun to unravel the mechanisms of interaction between Hippo signaling pathway and EMT. In this review, we describe the existing evidence of cross talk between Hippo signaling pathway key molecules and the process of EMT, with emphasis on the role of Hippo-EMT interplay in cancer.
Keywords: Cancer; Epithelial–mesenchymal transition (EMT); Hippo pathway; Snail; YAP/TAZ; ZEB.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.
References
-
- Zygulska AL, Krzemieniecki K, Pierzchalski P (2017) Hippo pathway—brief overview of its relevance in cancer. J Physiol Pharmacol 68(3):311–335 - PubMed
-
- Wang Y, Xu X, Maglic D, Dill MT, Mojumdar K, Ng PK, Jeong KJ, Tsang YH, Moreno D, Bhavana VH, Peng X, Ge Z, Chen H, Li J, Chen Z, Zhang H, Han L, Du D, Creighton CJ, Mills GB (2018) Comprehensive molecular characterization of the Hippo signaling pathway in cancer. Cell Rep 25(5):1304-1317.e5. https://doi.org/10.1016/j.celrep.2018.10.001 - DOI - PubMed - PMC
-
- Lian I, Kim J, Okazawa H, Zhao J, Zhao B, Yu J, Chinnaiyan A, Israel MA, Goldstein LS, Abujarour R, Ding S, Guan KL (2010) The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev 24(11):1106–1118. https://doi.org/10.1101/gad.1903310 - DOI - PubMed - PMC
-
- Morice S, Danieau G, Rédini F, Brounais-Le-Royer B, Verrecchia F (2020) Hippo/YAP signaling pathway: a promising therapeutic target in bone paediatric cancers? Cancers (Basel) 12(3):645. https://doi.org/10.3390/cancers12030645 - DOI
-
- Kalluri R, Weinberg RA (2009) The basics of epithelial–mesenchymal transition. J Clin Investig 119(6):1420–1428. https://doi.org/10.1172/JCI39104 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials